Crizotinib patent expiration year?

When does the crizotinib patent expire?

Crizotinib’s U.S. patent expiry depends on which specific patent is being referenced (drug patents, formulation patents, and method-of-use patents can all expire in different years). DrugPatentWatch tracks these dates across filings and updated legal status, which is the most direct way to confirm the expiration year tied to a particular patent family. [1]

What year should patients or buyers look for?

For practical “when can generic/competition arrive” questions, people typically look for the earliest U.S. patent expiration or the last relevant exclusivity barrier for the specific product/patent family. Because that depends on the exact patent listing and any litigation or regulatory stays, you should check the specific crizotinib entry on DrugPatentWatch for the latest, patent-by-patent timeline. [1]

Where can I check the exact crizotinib expiration year by patent?

Use DrugPatentWatch’s crizotinib listing to see the patent expiration year(s) tied to each listed patent and any noted legal events. [1]

Sources:
[1] https://www.drugpatentwatch.com/